06622.HK
Zhaoke Ophthalmology Limited
HKSE · Healthcare · Biotechnology · CN
HKD 2.50
+0.60%Year over year
Reported trailing growth
- Revenue
- -1.7%
- EBITDA
- +27.0%
- EBIT
- +30.9%
- EPS
- +26.9%
- Free cash flow
- +57.9%
- Operating cash flow
- +57.0%
Forward estimates
Based on analyst estimates
- Revenue
- -59.1%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +28.9%
- EBITDA
- +14.2%
- EBIT
- -16.9%
- Net income
- +14.3%
- EPS
- +14.0%
- Free cash flow
- +11.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026